XML 161 R84.htm IDEA: XBRL DOCUMENT v3.26.1
General Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 01, 2025
Oct. 15, 2024
Oct. 14, 2024
Jul. 20, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 23, 2025
Oct. 28, 2025
Aug. 09, 2024
General Information About Reporting Entity [line items]                    
Proceeds from public placement         $ 40,154 $ 0 $ 0      
Number of warrants in warrant exchange (in shares)               1    
ACT Genomics Holdings Company Limited                    
General Information About Reporting Entity [line items]                    
Consideration received $ 46,158   $ 46,000              
Percentage of voting equity interests acquired disposed (%) 73.27%                  
Class A warrants                    
General Information About Reporting Entity [line items]                    
Number of warrants issued (in shares)                 2,722,642  
Class B warrants                    
General Information About Reporting Entity [line items]                    
Number of warrants issued (in shares)                 2,722,642  
Placement agent warrants                    
General Information About Reporting Entity [line items]                    
Number of warrants issued (in shares)                 131,829  
Insighta                    
General Information About Reporting Entity [line items]                    
Proportion of the Group’s interest in the associate       50.00%            
Insighta                    
General Information About Reporting Entity [line items]                    
Percentage of shareholding of an equity accounted investee (%)   35.00% 35.00%              
Percentage of ownership interest disposed (%)     15.00%              
Consideration received     $ 30,000              
Europa Partners Holdings Limited                    
General Information About Reporting Entity [line items]                    
Percentage of voting equity interests acquired (%)                   100.00%